Predict your next investment

Ralexar Therapeutics company logo
HEALTHCARE | Drug Development
ralexar.com

See what CB Insights has to offer

Total Raised

$29.93M

Investors Count

4

Deal Terms

1

Ralexar Therapeutics Funding, Ralexar Therapeutics Valuation & Ralexar Therapeutics Revenue

4 Fundings

Ralexar Therapeutics's latest funding round was a Series C for $4.28M on January 4, 2019.

Ralexar Therapeutics's valuation in January 2014 was $52.69M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/4/2019

Series C

$4.28M

2

6/8/2017

Series B

$99M

10

1/23/2015

Grant

10

1/2/2014

Series A

$99M

$52.69M

10

Date

1/4/2019

6/8/2017

1/23/2015

1/2/2014

Round

Series C

Series B

Grant

Series A

Amount

$4.28M

$99M

$99M

Investors

Valuation

$52.69M

Revenue

Sources

2

10

10

10

Ralexar Therapeutics Deal Terms

1 Deal Term

Ralexar Therapeutics's deal structure is available for 1 funding round, including their Series A from January 02, 2014.

Round

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$99M

$99M

$99M

$99M

Ralexar Therapeutics Investors

4 Investors

Ralexar Therapeutics has 4 investors. New Science Ventures invested in Ralexar Therapeutics's Series C funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/2/2014

1/4/2019

3
Series A, Series B (2017), Series C (2019)

Venture Capital

New York

00/00/0000

00/00/0000

Third Point Ventures

Subscribe to see more

Corporate Venture

California

00/00/0000

00/00/0000

The Michael J. Fox Foundation

Subscribe to see more

Non-Profit Foundation

New York

00/00/0000

00/00/0000

Palo Alto Investors

Subscribe to see more

Other

California

First funding

1/2/2014

00/00/0000

00/00/0000

00/00/0000

Last Funding

1/4/2019

00/00/0000

00/00/0000

00/00/0000

Investor

Third Point Ventures

The Michael J. Fox Foundation

Palo Alto Investors

Rounds

3
Series A, Series B (2017), Series C (2019)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Corporate Venture

Non-Profit Foundation

Other

Location

New York

California

New York

California

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.